Literature DB >> 14265505

THIRD REPORT OF THE HUMAN KIDNEY TRANSPLANT REGISTRY.

J E MURRAY, R GLEASON, A BARTHOLOMAY.   

Abstract

Entities:  

Keywords:  MORTALITY; STATISTICS; UNITED STATES

Mesh：

Year:  1965        PMID： 14265505     DOI： 10.1097/00007890-196503000-00039

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  7 in total

1.  Legal aspects of human organ transplantation in Canada. I.

Authors:  J G Castel
Journal:  Can Med Assoc J       Date:  1968-09-28       Impact factor: 8.262

2.  Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy.

Authors:  T E Starzl; T L Marchioro; P I Terasaki; K A Porter; T D Faris; T J Herrmann; D L Vredevoe; M P Hutt; D A Ogden; W R Waddell
Journal:  Ann Surg       Date:  1965-10       Impact factor: 12.969

3.  Dilemma of irreversible renal failure.

Authors: 
Journal:  Br Med J       Date:  1967-03-11

4.  Human cadaveric renal transplantation. Report of twenty cases.

Authors:  J F Mowbray; S L Cohen; P B Doak; J R Kenyon; K Owen; A Percival; K A Porter; W S Peart
Journal:  Br Med J       Date:  1965-12-11

Review 5.  Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection.

Authors:  Roberto Marcén
Journal:  Drugs       Date:  2009-11-12       Impact factor: 9.546

Review 6.  Donor transmitted and de novo cancer after liver transplantation.

Authors:  Rajeev Desai; James Neuberger
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

7.  Comparative results of cadaver and related donor renal homografts in man, and immunologic implications of the outcome of second and paired transplants.

Authors:  D M Hume; H M Lee; G M Williams; H J White; J Ferré; J S Wolf; G R Prout; M Slapak; J O'Brien; S J Kilpatrick; H M Kauffman; R J Cleveland
Journal:  Ann Surg       Date:  1966-09       Impact factor: 12.969
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.